Status of bone mineral density in male patients with primary hypothyroidism
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 4
Abstract
Background. The issue of hypothyroidism effect on bone tissue is underinvestigated, due to the small number of studies. In addition, it’s not easy to determine the effect of reduced thyroid function on bone strength due to the fact that these patients are usually elderly and have many additional factors for the development of osteoporosis. The purpose of the study is to assess the status of bone mineral density (BMD) in men with hypothyroidism. Materials and methods. We have examined 35 men with primary hypothyroidism aged 28–69 years. Duration of disease (from the time of diagnosis and initiation of thyroid hormone replacement therapy) was 3 to 26 years. The average daily dose of levothyroxine was 125.5 ± 16.5 μg. Patients were in a state of compensation (no complaints and a normal level of thyroid-stimulating hormone on the background of hormone therapy). The control group consisted of 25 healthy, clinically euthyroid men aged 25–49 years. Results. Osteopenia of varying severity was detected in 11 (31.4 %), osteoporosis — in 8 (22.9 %) patients, and in the remaining 16 (45.7 %) persons, BMD was within normal limits. When comparing bone density graphs in patients of different age groups, it was found that with age, the frequency and severity of bone loss increases. Duration of disease has the most significant negative effect on the BMD in patients with hypothyroidism. Although the incidence of osteopenia in the group of patients with disease duration from 5 to 15 years is greater (55.0 %) than in persons with disease duration of more than 15 years (41.7 %), but osteoporosis is 2.5 times more likely in patients with longer duration of disease than in people with disease duration of 5–15 years. Conclusions. Violations of bone mineral density, which are manifested in the development of osteopenia and osteoporosis, are observed in 54.3 % of men with primary hypothyroidism. Severity of changes in bone mineral density is directly proportional to the age, duration of thyroid hormone replacement therapy and inversely proportional to the body mass index.
Authors and Affiliations
T. I. Kritskyy
Keywords
Related Articles
- EP ID EP630813
- DOI 10.22141/2224-0721.15.4.2019.174819
- Views 79
- Downloads 0
Quantitative and Qualitative Composition of Colonic Content Microbiota in Diabetes Mellitus Type 1 Patients with Concomitant Chronic Purulent Maxillary Sinusitis
There was performed a quantitative and qualitative assay of colonic content microbiota in 50 patients with diabetes mellitus (DM) type 1 and 47 patients with chronic purulent maxillary sinusitis and DM type 1 aged from 1...
Evaluation of Total Cardiovascular Risk in Patients with Hypertension and Impaired Glucose Tolerance
Aim. Timely reveal of the patients at high risk of cardiovascular diseases for whom earlier intervention for cardiovascular risk correction is the most effective. Materials and methods. Seventy patients aged 30–55 years...
The efficiency of Neuromidin in the comprehensive treatment of diabetic distal symmetric polyneuropathy
Background. The purpose of the study is to establish the efficiency and safety of the use of ipidacrine (Neuromidin) in patients with type 2 diabetes mellitus complicated by distal symmetric polyneuropathy. Materials and...
Antihyperglycemic therapy of elderly and senile patients in real clinical practice
The lecture deals with the topical issues of treating elderly and senile patients with diabetes mellitus (DM). The number of such people with type 2 DM is steadily increasing. The management of this category of patients...
New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...